Cancer de l’ovaire : prise en charge pluridisciplinaire du cancer de l’ovaire en première ligne: Recommandations Saint-Paul-de-Vence 2016

Bull Cancer. 2017 May:104 Suppl 1:S6-S15. doi: 10.1016/S0007-4551(17)30157-1.
[Article in French]

Abstract

Recommendations for the clinical practice of Nice-Saint-Paul de Vence The treatment of advanced epithelial ovarian cancer is multidisciplinary involving surgical teams and surgery and medical oncology, experienced in the management of this disease, following published quality criteria. The strategy must be validated in multidisciplinary consultation meeting (RCP) before any treatment. The pre-therapeutic assessment includes the histological diagnosis, evaluation of the tumor extension (biological assessment, markers, imaging, laparoscopy), assessment of the general state (operability), in order to answer the question of feasibility of an initial optimal surgery. The standard treatment involves complete surgical resections of the lesions by median laparotomy, followed by adjuvant chemotherapy based on carboplatin and paclitaxel, six cycles with the possibility of treatment with bevacizumab during adjuvant treatment and in maintenance. If complete surgery is not feasible as a result of the initial assessment, interval debulking surgery is considered after 3 to 4 courses of induction chemotherapy.

Keywords: Cancer de l’ovaire; First line; Multidisciplinarity; Ovarian cancer; Pluridisciplinarité; Prise en charge initiale.

Publication types

  • Practice Guideline

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Carboplatin / administration & dosage
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Induction Chemotherapy
  • Maintenance Chemotherapy
  • Neoplasm Staging
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery*
  • Paclitaxel / administration & dosage
  • Preoperative Care

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab
  • Carboplatin
  • Paclitaxel